Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. healthy individual aged 19 years and above at consent. 2. individual willing to provide written informed consent to participate study voluntarily. 3. individuals who can be followed up during the study period and can comply with the study requirements. 4. individual who agrees not to donate blood during the study participation 5. females of childbearing potential with negative serum or urinary pregnancy test on the day of screening. 6. females of childbearing potential who are using an effective birth control method for at least 4 weeks before the screening and during the study participation.

inclusion criteria: 1. healthy individual aged 19 years and above at consent. 2. individual willing to provide written informed consent to participate study voluntarily. 3. individuals who can be followed up during the study period and can comply with the study requirements. 4. individual who agrees not to donate blood during the study participation 5. females of childbearing potential with negative serum or urinary pregnancy test on the day of screening. 6. females of childbearing potential who are using an effective birth control method for at least 4 weeks before the screening and during the study participation.

Sept. 1, 2022, 10 p.m. usa

inclusion criteria: healthy individual aged 19 years and above at consent. individual willing to provide written informed consent to participate study voluntarily. individuals who can be followed up during the study period and can comply with the study requirements. individual who agrees not to donate blood during the study participation females of childbearing potential with negative serum or urinary pregnancy test on the day of screening. females of childbearing potential who are using an effective birth control method for at least 4 weeks before the screening and during the study participation.

inclusion criteria: healthy individual aged 19 years and above at consent. individual willing to provide written informed consent to participate study voluntarily. individuals who can be followed up during the study period and can comply with the study requirements. individual who agrees not to donate blood during the study participation females of childbearing potential with negative serum or urinary pregnancy test on the day of screening. females of childbearing potential who are using an effective birth control method for at least 4 weeks before the screening and during the study participation.